MEDX
Horizon Kinetics Medical ETF
Price Chart
Latest Quote
$35.15
+0.41 (+1.17%)
Current Price
| Previous Close | $34.74 |
| Open | $35.15 |
| Day High | $35.15 |
| Day Low | $35.15 |
| Volume | 89 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.19% |
| Net Assets | $18.68M |
| Expense Ratio | 0.85% |
| Category | Health |
| Fund Family | Horizon Kinetics |
| Net Asset Value | $34.82 |
| Premium/Discount | 0.93% |
| Quarterly Dividend Yield | 1.19% |
| P/E Ratio | 27.07 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $34.24 |
| SMA50 | $33.39 |
| SMA200 | $32.72 |
| RSI | 67.83 |
| ATR | 0.3874 |
| Rel Volume | 0.05 |
Performance History
| Week | +2.80% |
| Month | +4.25% |
| Quarter | +9.76% |
| 6 Months | +5.95% |
| YTD | +5.89% |
| Year | +34.10% |
| 3 Years | +23.02% |
| 10 Years | +22.86% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $35.15 | 89 |
| 2026-06-23 | $34.84 | 7,100 |
| 2026-06-22 | $34.39 | 4,500 |
| 2026-06-18 | $33.88 | 200 |
| 2026-06-17 | $34.23 | 900 |
| 2026-06-16 | $34.19 | 800 |
| 2026-06-15 | $34.33 | 400 |
| 2026-06-12 | $34.49 | 1,200 |
| 2026-06-11 | $34.74 | 100 |
| 2026-06-10 | $34.16 | 200 |
| 2026-06-09 | $34.45 | 900 |
| 2026-06-08 | $34.18 | 12,500 |
| 2026-06-05 | $34.48 | 400 |
| 2026-06-04 | $34.50 | 1,200 |
| 2026-06-03 | $33.48 | 500 |
| 2026-06-02 | $33.17 | 1,100 |
| 2026-06-01 | $33.60 | 1,500 |
| 2026-05-29 | $34.30 | 900 |
| 2026-05-28 | $34.36 | 1,400 |
| 2026-05-27 | $33.94 | 100 |
| 2026-05-26 | $33.62 | 3,500 |
About Horizon Kinetics Medical ETF
The fund is an actively-managed exchange-traded fund (“ETF”) that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries. The fund is non-diversified.
📰 Latest News
When Should You Buy medmix AG (VTX:MEDX)?
Simply Wall St. • 2026-06-11T04:05:33Z
Medical ETF (MEDX) Touches New 52-Week High
Zacks • 2026-02-24T13:28:00Z
Owning 41% in medmix AG (VTX:MEDX) means that insiders are heavily invested in the company's future
Simply Wall St. • 2026-02-04T04:22:35Z
medmix (VTX:MEDX) Could Be Struggling To Allocate Capital
Simply Wall St. • 2025-12-20T06:18:38Z
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Zacks • 2025-11-24T12:00:00Z
Is It Too Late To Consider Buying medmix AG (VTX:MEDX)?
Simply Wall St. • 2025-10-18T08:04:42Z
A Look At The Fair Value Of medmix AG (VTX:MEDX)
Simply Wall St. • 2025-09-17T07:54:02Z
medmix AG's (VTX:MEDX) top owners are private companies with 41% stake, while 35% is held by individual investors
Simply Wall St. • 2025-08-27T13:51:41Z
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
Zacks • 2025-08-08T15:00:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.